The company may be the beneficiary of another social media-inspired buying frenzy.
Compare LHDX Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Lucira Health, Inc.
News & Analysis: Lucira Health, Inc.
This start-up's over-the-counter COVID-19 tests could be a huge hit.
LHDX earnings call for the period ending March 31, 2021.
This coronavirus testing stock has taken shareholders on a roller-coaster ride since its IPO.
This analyst thinks the company's stock performance will trail that of the market.
The company's COVID-19 Test Kit will soon be available for sale at a pharmacy near you.